AMRI makes three promotions

To strengthen sales operations in US and Europe

Albany Molecular Research Inc (AMRI) has promoted Mark Sawicki to vice president of business development for Europe. Dr Sawicki was previously responsible for sales activities for AMRI discovery services in North America and Europe as senior director of business development. He joined AMRI in 2004 as director of business development.

Christopher Conway has been promoted to senior director of business development for North American Discovery Services. Prior to joining AMRI in 2008 as manager of business development, Conway held sales positions of increasing responsibility at Johnson & Johnson, culminating in the role of district manager for the firm’s Ortho-McNeil Neurologics Division.

Angie Urdanoff has moved up to senior director, sales operations. Before joining AMRI, Urdanoff worked for Pitney Bowes Business Insight as managing director of Americas sales operations. Prior to that, she was product and manufacturing manager at GE Silicones.

‘As AMRI continues to add locations and expand the breadth of its products and services, we are also increasing the scope of our sales activities with the goal of expanding our market share,’ said AMRI ceo Thomas D’Ambra.

‘We are proud to recognise the contributions of these key individuals, congratulate them on this important step, and wish them great success in their new roles.’

You may also like

Training & Education

Curia and Carterra partner on biologics symposium to further biotechnology research

The companies will run the high-throughput biologics symposium with a focus on the development of enhanced mouse systems for antibody generation and high-throughput single B cell screening
Research & Development

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA

Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA)
Drug Delivery

Curia and MilliporeSigma sign deal for use of cell line for proteins and antibodies

Following this agreement, the CHOZN GS-/- cell line has been integrated into Curia’s cell line development workflow and is immediately available to Curia customers
Manufacturing

Curia reveals continuous-flow collaboration with Corning

Continuous flow chemistry is critical for the development and manufacture of pharmaceutical intermediates and APIs
Research & Development

AMRI manufactures lipid excipients for Pfizer-BioNTech COVID-19 vaccine

AMRI has been providing development, scale-up and manufacturing services at a number of its global R&D and production sites for several months
Manufacturing

ViralClear partners with CDMO on potential COVID-19 treatment Merimepodib

ViralClear Pharmaceuticals has partnered with Albany Molecular Research Inc (AMRI) on the manufacture of Merimepodib API either as a stand-alone treatment or in combination with other antiviral agents or immune modulator
Manufacturing

AMRI to acquire Euticals

Strategic transaction expands API development and manufacturing business
Subscribe now